510(k) for Metra Biosystems' bone resorption immunoassay:
This article was originally published in Clinica
Executive Summary
Metra Biosystems of Mountain View, California, will market its Pyrilinks-D bone resorption immunoassay to monitor patient response to hormone replacement therapy used in the treatment and prevention of osteoporosis.